Compare THRY & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | THRY | BHST |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | Canada |
| Employees | N/A | 87 |
| Industry | Industrial Machinery/Components | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.8M | 104.2M |
| IPO Year | 2020 | N/A |
| Metric | THRY | BHST |
|---|---|---|
| Price | $2.80 | $4.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $9.33 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 873.5K | 17.5K |
| Earning Date | 04-30-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.50 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $785,015,000.00 | N/A |
| Revenue This Year | N/A | $146.27 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $276.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.91 | $4.10 |
| 52 Week High | $15.49 | $12.80 |
| Indicator | THRY | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 44.34 | 48.42 |
| Support Level | $2.47 | $4.19 |
| Resistance Level | $3.69 | $4.96 |
| Average True Range (ATR) | 0.23 | 0.21 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 57.63 | 33.33 |
Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.